SPS
DNA icon

Susquehanna Portfolio Strategies’s Ginkgo Bioworks DNA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$777K Buy
126,720
+49,518
+64% +$412K 0.01% 679
2025
Q4 		$642K Sell
77,202
-31,780
-29% -$342K 0.01% 726
2025
Q3 		$1.59M Buy
+108,982
New +$1.3M 0.03% 560

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Portfolio Strategies's DNA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies increased its Ginkgo Bioworks (DNA) stake by 64% in Q1 2026, buying an estimated $412K and bringing the position to 126,720 shares worth $777K. The position accounts for 0.01% of the portfolio, ranked #679.

Susquehanna Portfolio Strategies first reported a position in DNA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.59M in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Susquehanna Portfolio Strategies held 126,720 shares of Ginkgo Bioworks worth $777K as of Q1 2026.
  • Susquehanna Portfolio Strategies bought 49,518 Ginkgo Bioworks shares in Q1 2026, an estimated $412K.
  • Ginkgo Bioworks made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #679 holding.
  • Susquehanna Portfolio Strategies first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's Ginkgo Bioworks position peaked at $1.59M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.